WHO warns of immunisation strategy gaps amid measles outbreaks
The World Health Organisation (WHO) has reported a sharp drop in deaths from measles in recent decades yet warned that…
28 Nov 2025
Celltrion secures Health Canada go-ahead for Eylea biosimilar
South Korean biopharma Celltrion has obtained regulatory approval for its Eylea (aflibercept) biosimilar, Eydenzelt, from Health Canada. The therapy will now be available in both a pre-filled syringe and a…
28 Nov 2025
Over half of European HIV patients diagnosed late, ECDC report finds
A European 2025 HIV/AIDS surveillance report has revealed that countries within the continent are currently failing to test and treat HIV early. The annual report, published by the European Centre…
28 Nov 2025
IASO Bio gains Hong Kong approval for Fucaso application
IASO Biotechnology has received the Hong Kong Department of Health's approval for its biologics licence application (BLA) for the fully human anti-B-cell maturation antigen (BCMA) chimeric antigen receptor T-cell (CAR-T)…
28 Nov 2025
MHRA approves Roche’s inavolisib for breast cancer
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval to Roche's Itovebi (inavolisib) to treat adults with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer.…
27 Nov 2025
Valneva trims R&D footprint by shutting French facility
Not long after cutting its sales forecast for 2025, Valneva has decided to decrease its operational footprint in France by shutting a facility tasked with both operational and research and…
27 Nov 2025
SK bolsters oncology pipeline in radiopharmaceutical licensing deal
SK Biopharmaceuticals has in-licensed its second radiopharmaceutical – this time from a US-based academic organisation – in a bid to enhance its oncology pipeline. Through its deal with the Wisconsin…